183 related articles for article (PubMed ID: 21829161)
1. Visceral obesity modulates the impact of apolipoprotein C3 gene variants on liver fat content.
Peter A; Kantartzis K; Machicao F; Machann J; Wagner S; Templin S; Königsrainer I; Königsrainer A; Schick F; Fritsche A; Häring HU; Stefan N
Int J Obes (Lond); 2012 Jun; 36(6):774-82. PubMed ID: 21829161
[TBL] [Abstract][Full Text] [Related]
2. Genetic variation in PNPLA3 but not APOC3 influences liver fat in non-alcoholic fatty liver disease.
Hyysalo J; Stojkovic I; Kotronen A; Hakkarainen A; Sevastianova K; Makkonen J; Lundbom N; Rissanen A; Krauss RM; Melander O; Orho-Melander M; Yki-Järvinen H
J Gastroenterol Hepatol; 2012 May; 27(5):951-6. PubMed ID: 22141340
[TBL] [Abstract][Full Text] [Related]
3. The DGAT2 gene is a candidate for the dissociation between fatty liver and insulin resistance in humans.
Kantartzis K; Machicao F; Machann J; Schick F; Fritsche A; Häring HU; Stefan N
Clin Sci (Lond); 2009 Mar; 116(6):531-7. PubMed ID: 18980578
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease.
Petersen KF; Dufour S; Hariri A; Nelson-Williams C; Foo JN; Zhang XM; Dziura J; Lifton RP; Shulman GI
N Engl J Med; 2010 Mar; 362(12):1082-9. PubMed ID: 20335584
[TBL] [Abstract][Full Text] [Related]
5. Association between plasma lipid parameters and APOC3 genotypes in Brazilian subjects: effect of gender, smoking and APOE genotypes.
Fiegenbaum M; de Andrade FM; Hutz MH
Clin Chim Acta; 2007 May; 380(1-2):175-81. PubMed ID: 17367769
[TBL] [Abstract][Full Text] [Related]
6. The APOC3 T-455C and C-482T promoter region polymorphisms are not associated with the severity of liver damage independently of PNPLA3 I148M genotype in patients with nonalcoholic fatty liver.
Valenti L; Nobili V; Al-Serri A; Rametta R; Leathart JB; Zappa MA; Dongiovanni P; Fracanzani AL; Alterio A; Roviaro G; Daly AK; Fargion S; Day CP
J Hepatol; 2011 Dec; 55(6):1409-14. PubMed ID: 21777557
[TBL] [Abstract][Full Text] [Related]
7. Lack of effect of apolipoprotein C3 polymorphisms on indices of liver steatosis, lipid profile and insulin resistance in obese Southern Europeans.
Sentinelli F; Romeo S; Maglio C; Incani M; Burza MA; Scano F; Coccia F; Cossu E; Leonetti F; Baroni MG
Lipids Health Dis; 2011 Jun; 10():93. PubMed ID: 21663607
[TBL] [Abstract][Full Text] [Related]
8. Abdominal fat interacts with PNPLA3 I148M, but not with the APOC3 variant in the pathogenesis of liver steatosis in chronic hepatitis C.
Zampino R; Coppola N; Cirillo G; Boemio A; Pisaturo M; Marrone A; Macera M; Sagnelli E; Perrone L; Adinolfi LE; Miraglia del Giudice E
J Viral Hepat; 2013 Aug; 20(8):517-23. PubMed ID: 23808989
[TBL] [Abstract][Full Text] [Related]
9. Association of APOA5 and APOC3 gene polymorphisms with plasma apolipoprotein A5 level in patients with metabolic syndrome.
Niculescu LS; Vlădică M; Sima AV
Biochem Biophys Res Commun; 2010 Jan; 391(1):587-91. PubMed ID: 19932084
[TBL] [Abstract][Full Text] [Related]
10. Gender- and obesity-specific effect of apolipoprotein C3 gene (APOC3) -482C>T polymorphism on triglyceride concentration in Turkish adults.
Coban N; Onat A; Guclu-Geyik F; Komurcu-Bayrak E; Sansoy V; Hergenc G; Can G; Erginel-Unaltuna N
Clin Chem Lab Med; 2011 Oct; 50(2):285-92. PubMed ID: 22004016
[TBL] [Abstract][Full Text] [Related]
11. Dissociation between fatty liver and insulin resistance in humans carrying a variant of the patatin-like phospholipase 3 gene.
Kantartzis K; Peter A; Machicao F; Machann J; Wagner S; Königsrainer I; Königsrainer A; Schick F; Fritsche A; Häring HU; Stefan N
Diabetes; 2009 Nov; 58(11):2616-23. PubMed ID: 19651814
[TBL] [Abstract][Full Text] [Related]
12. Novel obesity risk loci do not determine distribution of body fat depots: a whole-body MRI/MRS study.
Haupt A; Thamer C; Heni M; Machicao F; Machann J; Schick F; Stefan N; Fritsche A; Häring HU; Staiger H
Obesity (Silver Spring); 2010 Jun; 18(6):1212-7. PubMed ID: 19910938
[TBL] [Abstract][Full Text] [Related]
13. APOC3 Protein Is Not a Predisposing Factor for Fat-induced Nonalcoholic Fatty Liver Disease in Mice.
Cheng X; Yamauchi J; Lee S; Zhang T; Gong Z; Muzumdar R; Qu S; Dong HH
J Biol Chem; 2017 Mar; 292(9):3692-3705. PubMed ID: 28115523
[TBL] [Abstract][Full Text] [Related]
14. Liver fat in obesity: role of type 2 diabetes mellitus and adipose tissue distribution.
Bozzetto L; Prinster A; Mancini M; Giacco R; De Natale C; Salvatore M; Riccardi G; Rivellese AA; Annuzzi G
Eur J Clin Invest; 2011 Jan; 41(1):39-44. PubMed ID: 20825466
[TBL] [Abstract][Full Text] [Related]
15. Genetic Variation in the 11β-hydroxysteroid-dehydrogenase 1 Gene Determines NAFLD and Visceral Obesity.
Lutz SZ; Peter A; Machicao F; Lamprinou A; Machann J; Schick F; Königsrainer I; Königsrainer A; Fritsche A; Staiger H; Häring HU; Stefan N; Kantartzis K
J Clin Endocrinol Metab; 2016 Dec; 101(12):4743-4751. PubMed ID: 27715400
[TBL] [Abstract][Full Text] [Related]
16. A gene variant of PNPLA3, but not of APOC3, is associated with histological parameters of NAFLD in an obese population.
Verrijken A; Beckers S; Francque S; Hilden H; Caron S; Zegers D; Ruppert M; Hubens G; Van Marck E; Michielsen P; Staels B; Taskinen MR; Van Hul W; Van Gaal L
Obesity (Silver Spring); 2013 Oct; 21(10):2138-45. PubMed ID: 23512881
[TBL] [Abstract][Full Text] [Related]
17. Abdominal obesity and hyperglycemia mask the effect of a common APOC3 haplotype on the risk of myocardial infarction.
Ruiz-Narváez EA; Sacks FM; Campos H
Am J Clin Nutr; 2008 Jun; 87(6):1932-8. PubMed ID: 18541587
[TBL] [Abstract][Full Text] [Related]
18. Impact of variation near MC4R on whole-body fat distribution, liver fat, and weight loss.
Haupt A; Thamer C; Heni M; Tschritter O; Machann J; Schick F; Machicao F; Häring HU; Staiger H; Fritsche A
Obesity (Silver Spring); 2009 Oct; 17(10):1942-5. PubMed ID: 19629057
[TBL] [Abstract][Full Text] [Related]
19. [Association between APOC3 promoter region polymorphisms and non-alcoholic fatty liver disease].
Niu T; Jiang M; Liu H; Jiang X; Lin Z; Zhang M; Wang J; Geng N; Xin Y; Xuan S
Zhonghua Gan Zang Bing Za Zhi; 2014 May; 22(5):374-9. PubMed ID: 25180874
[TBL] [Abstract][Full Text] [Related]
20. C825T polymorphism of the G protein beta3 subunit is associated with obesity but not with insulin sensitivity.
Stefan N; Stumvoll M; Machicao F; Koch M; Häring HU; Fritsche A
Obes Res; 2004 Apr; 12(4):679-83. PubMed ID: 15090636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
